BN k nm PA-To The Moon - Tiger Brokers Online Investing Community - To The Moon

2
Comment
Favorite

EGOoi
01-09

BN k nm PA

HK Movers | MiniMax Soars 90%, Ribo Surges 33%, Jinxun Resources Jumps 22% on Debut

Chinese AI firm $MiniMax(00100)$ jumped 40% on debut in the Hong Kong.Founded in early 2022 by Yan Junjie, a former senior executive at SenseTime, MiniMax has positioned itself as a developer of...

HK Movers | MiniMax Soars 90%, Ribo Surges 33%, Jinxun Resources Jumps 22% on Debut

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

2

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":519749891839040,"tweetId":"519749891839040","gmtCreate":1767940334093,"gmtModify":1767940337260,"author":{"id":3575777075738080,"idStr":"3575777075738080","authorId":3575777075738080,"authorIdStr":"3575777075738080","name":"EGOoi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>BN k nm PA</p></body></html>","htmlText":"<html><head></head><body><p>BN k nm PA</p></body></html>","text":"BN k nm PA","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/519749891839040","repostId":1157059158,"repostType":4,"repost":{"id":"1157059158","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1767937427,"share":"https://ttm.financial/m/news/1157059158?lang=en_US&edition=fundamental","pubTime":"2026-01-09 13:43","market":"hk","language":"en","title":"HK Movers | MiniMax Soars 90%, Ribo Surges 33%, Jinxun Resources Jumps 22% on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1157059158","media":"Tiger Newspress","summary":"Chinese AI firm $MiniMax(00100)$ jumped 40% on debut in the Hong Kong.Founded in early 2022 by Yan Junjie, a former senior executive at SenseTime, MiniMax has positioned itself as a developer of...","content":"<html><head></head><body><p>Chinese AI firm <strong><a href=\"https://laohu8.com/S/00100\">MiniMax</a></strong> jumped 90% on debut in the Hong Kong.</p><p>Founded in early 2022 by Yan Junjie, a former senior executive at SenseTime, MiniMax has positioned itself as a developer of so-called multimodal AI models, capable of processing and generating content across text, images, audio, video, and music. Its products, including MiniMax M1, Hailuo-02, Speech-02, and Music-01, place it in direct competition with a growing cohort of Chinese startups racing to build broad-based AI systems that can be deployed across consumer apps, enterprise services, and creative industries.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/17daadcb006239ccd1194c94f709f0cb\" tg-width=\"536\" tg-height=\"140\"/></p><p>Copper cathodes manufacturer <strong><a href=\"https://laohu8.com/S/03636\">Jinxun Resources</a></strong> jumped 22% on debut in the Hong Kong.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/d4fe3d87b18887247a732cf6472c86ea\" tg-width=\"537\" tg-height=\"132\"/></p><p>Chinese RNA-based medicine developer <strong><a href=\"https://laohu8.com/S/06938\">Ribo Life Science</a></strong> jumped 33% on debut in the Hong Kong.</p><p>According to its latest prospectus, Ribo’s revenue rose 56.6% to 103.8 million yuan ($14.7 million) in the first six months of this year from 66.3 million yuan a year earlier. Its loss over that time narrowed to 97.8 million yuan from 141.6 million yuan a year earlier.</p><p style=\"text-align: start;\">Founded in 2007 and with numerous years of experience in RNA-based nucleotide drug development, the Suzhou-based company specializes in therapies using small interfering RNA (siRNA), which block the actions of genes responsible for a host of diseases. The company says it has one of the world’s largest siRNA pipelines, including seven clinical-stage candidate drugs aimed at cardiovascular, metabolic, renal and liver diseases. Four of those are already in Phase Two clinical trials.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/06e36f92f9a49f78f762db65014dfbd0\" tg-width=\"534\" tg-height=\"132\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK Movers | MiniMax Soars 90%, Ribo Surges 33%, Jinxun Resources Jumps 22% on Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK Movers | MiniMax Soars 90%, Ribo Surges 33%, Jinxun Resources Jumps 22% on Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2026-01-09 13:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Chinese AI firm <strong><a href=\"https://laohu8.com/S/00100\">MiniMax</a></strong> jumped 90% on debut in the Hong Kong.</p><p>Founded in early 2022 by Yan Junjie, a former senior executive at SenseTime, MiniMax has positioned itself as a developer of so-called multimodal AI models, capable of processing and generating content across text, images, audio, video, and music. Its products, including MiniMax M1, Hailuo-02, Speech-02, and Music-01, place it in direct competition with a growing cohort of Chinese startups racing to build broad-based AI systems that can be deployed across consumer apps, enterprise services, and creative industries.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/17daadcb006239ccd1194c94f709f0cb\" tg-width=\"536\" tg-height=\"140\"/></p><p>Copper cathodes manufacturer <strong><a href=\"https://laohu8.com/S/03636\">Jinxun Resources</a></strong> jumped 22% on debut in the Hong Kong.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/d4fe3d87b18887247a732cf6472c86ea\" tg-width=\"537\" tg-height=\"132\"/></p><p>Chinese RNA-based medicine developer <strong><a href=\"https://laohu8.com/S/06938\">Ribo Life Science</a></strong> jumped 33% on debut in the Hong Kong.</p><p>According to its latest prospectus, Ribo’s revenue rose 56.6% to 103.8 million yuan ($14.7 million) in the first six months of this year from 66.3 million yuan a year earlier. Its loss over that time narrowed to 97.8 million yuan from 141.6 million yuan a year earlier.</p><p style=\"text-align: start;\">Founded in 2007 and with numerous years of experience in RNA-based nucleotide drug development, the Suzhou-based company specializes in therapies using small interfering RNA (siRNA), which block the actions of genes responsible for a host of diseases. The company says it has one of the world’s largest siRNA pipelines, including seven clinical-stage candidate drugs aimed at cardiovascular, metabolic, renal and liver diseases. Four of those are already in Phase Two clinical trials.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/06e36f92f9a49f78f762db65014dfbd0\" tg-width=\"534\" tg-height=\"132\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00100":"MINIMAX-WP","03636":"金浔资源","06938":"瑞博生物-B"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157059158","content_text":"Chinese AI firm MiniMax jumped 90% on debut in the Hong Kong.Founded in early 2022 by Yan Junjie, a former senior executive at SenseTime, MiniMax has positioned itself as a developer of so-called multimodal AI models, capable of processing and generating content across text, images, audio, video, and music. Its products, including MiniMax M1, Hailuo-02, Speech-02, and Music-01, place it in direct competition with a growing cohort of Chinese startups racing to build broad-based AI systems that can be deployed across consumer apps, enterprise services, and creative industries.Copper cathodes manufacturer Jinxun Resources jumped 22% on debut in the Hong Kong.Chinese RNA-based medicine developer Ribo Life Science jumped 33% on debut in the Hong Kong.According to its latest prospectus, Ribo’s revenue rose 56.6% to 103.8 million yuan ($14.7 million) in the first six months of this year from 66.3 million yuan a year earlier. Its loss over that time narrowed to 97.8 million yuan from 141.6 million yuan a year earlier.Founded in 2007 and with numerous years of experience in RNA-based nucleotide drug development, the Suzhou-based company specializes in therapies using small interfering RNA (siRNA), which block the actions of genes responsible for a host of diseases. The company says it has one of the world’s largest siRNA pipelines, including seven clinical-stage candidate drugs aimed at cardiovascular, metabolic, renal and liver diseases. Four of those are already in Phase Two clinical trials.","news_type":1,"symbols_score_info":{"00100":2,"06938":2,"03636":2}},"isVote":1,"tweetType":1,"viewCount":132,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}